Back

Assessment of novel oral anticoagulant use in real-world setting: importance of a structured anticoagulation unit

18 March 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Atrial fibrillation - Clinical Atrial Fibrillation - Stroke Prevention - Oral Anticoagulation EHRA Premium Access EHRA 2018

About the speaker

Photo
Doctor Andre Monteiro

Hospital Divino Espirito Santo, Ponta Delgada (Portugal)

28 More presentations in this session

Presentation thumbnail
Epworth sleepness scale and Berlin questionnaire: A comparison in a Tunisian population with non valvular atrial fibrillation
Doctor S. Ouali (Tunis, TN)
Abstract Slides
Presentation thumbnail
Hypertension and atrial fibrillation: an association that increases the risk of developing obstructive sleep apnea in a Tunisian population
Doctor S. Ouali (Tunis, TN)
Abstract Slides
Presentation thumbnail
Left atrial pressure correlates with atrial sphericity but not with the degree of atrial dilatation and scar burden, in patients who underwent pulmonary vein isolation.
Doctor A. Margulescu (Swansea, GB)
Abstract Slides
Presentation thumbnail
AF type and low voltage areas: biomarkers distinguish AF progression phenotypes
Associate Professor J. Kornej (Boston, US)
Abstract
Presentation thumbnail
Triple therapy is superior to dual anti-platelet therapy in atrial fibrillation patients experiencing acute myocardial infarction with percutaneous coronary intervention
Associate Professor K. Lee (Gwangju, KR)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1 - Atrial fibrillation - Clinical

The Event

Event poster

EHRA 2018

18 March - 20 March 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources